Verve Therapeutics Inc (VERV) — Financial Flexibility Index
Verve Therapeutics Inc (VERV) has a Financial Flexibility Index of -0.19x as of March 2025. Free cash flow of $-26.62 Million (operating CF $-27.84 Million minus capex $1.22 Million) represents 0% of total liabilities ($140.65 Million). Also explore Verve Therapeutics Inc (VERV) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verve Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Verve Therapeutics Inc across 6 annual periods. Check how strategically is Verve Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Verve Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Verve Therapeutics Inc. For the full company profile including market capitalisation, see Verve Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-153.96 Million | $-157.69 Million | $153.99 Million | ▼ -9.2% |
| 2023 | -0.92x | $-140.27 Million | $-149.55 Million | $153.19 Million | ▼ -7.7% |
| 2022 | -0.85x | $-109.10 Million | $-122.33 Million | $128.29 Million | ▲ +69.0% |
| 2021 | -2.75x | $-73.52 Million | $-77.88 Million | $26.77 Million | ▼ -1127.5% |
| 2020 | -0.22x | $-31.84 Million | $-35.27 Million | $142.32 Million | ▼ -65.0% |
| 2019 | -0.14x | $-5.58 Million | $-7.44 Million | $41.20 Million | — |